Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trialLore Vanderbeke, Nico Janssen, Dennis C. J. J. Bergmans et al.|Intensive Care Medicine|2021Cited by 98
Clinical Impact of Polymerase Chain Reaction–Based <i>Aspergillus</i> and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter StudySammy Huygens, Bart Rijnders, Saskia K. Klein et al.|Clinical Infectious Diseases|2023Cited by 57
Diagnostic Value of Microbial Cell-free DNA Sequencing for Suspected Invasive Fungal Infections: A Retrospective Multicenter Cohort StudySammy Huygens, Bart Rijnders, Alexander Schauwvlieghe et al.|Open Forum Infectious Diseases|2024Cited by 29
Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological DiseaseJochem B. Buil, Bart Rijnders, Sammy Huygens et al.|Journal of Clinical Microbiology|2023Cited by 24
Multicenter validation of a galactomannan chemiluminescence immunoassay for the diagnosis of pulmonary aspergillosis on serum of patients with hematological diseaseHanne Lamberink, Bart Rijnders, Sammy Huygens et al.|Journal of Clinical Microbiology|2025Cited by 4